These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34631791)

  • 21. LncRNA MIR497HG inhibits proliferation and migration of retinal endothelial cells under high-level glucose treatment via miRNA-128-3p/SIRT1 axis.
    Yang J; Yang FJ; Wang YG; Su GF; Miao X
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):5871-5877. PubMed ID: 32572899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell density sensing alters TGF-β signaling in a cell-type-specific manner, independent from Hippo pathway activation.
    Nallet-Staub F; Yin X; Gilbert C; Marsaud V; Ben Mimoun S; Javelaud D; Leof EB; Mauviel A
    Dev Cell; 2015 Mar; 32(5):640-51. PubMed ID: 25758862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanisms underlying TGF-ß/Hippo signaling crosstalks - Role of baso-apical epithelial cell polarity.
    Ben Mimoun S; Mauviel A
    Int J Biochem Cell Biol; 2018 May; 98():75-81. PubMed ID: 29544895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.
    Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC
    Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling.
    Zhou Y; Shan T; Ding W; Hua Z; Shen Y; Lu Z; Chen B; Dai T
    J Cell Physiol; 2018 Aug; 233(8):5805-5814. PubMed ID: 29215734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D3 analogue facilitates epithelial wound healing through promoting epithelial-mesenchymal transition via the Hippo pathway.
    Wang D; Lin L; Lei K; Zeng J; Luo J; Yin Y; Li Y; Zhang L; Nie X; Zuo D; Sun L
    J Dermatol Sci; 2020 Nov; 100(2):120-128. PubMed ID: 32938565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer.
    Noguchi S; Saito A; Nagase T
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Crosstalk of Hippo/YAP and Wnt/β-catenin pathways].
    Xu F; Zhang J; Ma D
    Yi Chuan; 2014 Feb; 36(2):95-102. PubMed ID: 24846937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGF-β1 regulates the expression and transcriptional activity of TAZ protein via a Smad3-independent, myocardin-related transcription factor-mediated mechanism.
    Miranda MZ; Bialik JF; Speight P; Dan Q; Yeung T; Szászi K; Pedersen SF; Kapus A
    J Biol Chem; 2017 Sep; 292(36):14902-14920. PubMed ID: 28739802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer cells through TGF-β/Smad signaling pathway.
    Zhao JJ; Hao S; Wang LL; Hu CY; Zhang S; Guo LJ; Zhang G; Gao B; Jiang Y; Tian WG; Luo DL
    Oncotarget; 2016 Sep; 7(36):57903-57918. PubMed ID: 27507052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.
    Rashidian J; Le Scolan E; Ji X; Zhu Q; Mulvihill MM; Nomura D; Luo K
    Sci Signal; 2015 Feb; 8(363):ra14. PubMed ID: 25670202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of miR-101a Suppresses Chronic Renal Fibrosis by Regulating KDM3A via Blockade of the YAP-TGF-β-Smad Signaling Pathway.
    Ding H; Xu Y; Jiang N
    Mol Ther Nucleic Acids; 2020 Mar; 19():1276-1289. PubMed ID: 32092824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA MALAT1 regulates diabetic cardiac fibroblasts through the Hippo-YAP signaling pathway.
    Liu J; Xu L; Zhan X
    Biochem Cell Biol; 2020 Oct; 98(5):537-547. PubMed ID: 32069074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
    Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
    Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SKP2 and OTUD1 govern non-proteolytic ubiquitination of YAP that promotes YAP nuclear localization and activity.
    Yao F; Xiao Z; Sun Y; Ma L
    Cell Stress; 2018 Aug; 2(9):233-235. PubMed ID: 31225491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma.
    Wang H; Pan JQ; Luo L; Ning XJ; Ye ZP; Yu Z; Li WS
    Mol Cancer; 2015 Feb; 14():2. PubMed ID: 25971746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The long-noncoding RNA MALAT1 regulates TGF-β/Smad signaling through formation of a lncRNA-protein complex with Smads, SETD2 and PPM1A in hepatic cells.
    Zhang J; Han C; Song K; Chen W; Ungerleider N; Yao L; Ma W; Wu T
    PLoS One; 2020; 15(1):e0228160. PubMed ID: 31995604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WW Domain-Containing Proteins YAP and TAZ in the Hippo Pathway as Key Regulators in Stemness Maintenance, Tissue Homeostasis, and Tumorigenesis.
    Chen YA; Lu CY; Cheng TY; Pan SH; Chen HF; Chang NS
    Front Oncol; 2019; 9():60. PubMed ID: 30805310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge.
    Piersma B; Bank RA; Boersema M
    Front Med (Lausanne); 2015; 2():59. PubMed ID: 26389119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.